Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Lamictal

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

80 API Suppliers, 33 USDMF, 21 CEP/COS, 5 JDMF, 21 EU WC, 10 KDMF, 20 NDC API, 43 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1205 FDF Dossiers, 235 FDA Orange Book, 725 Europe, 32 Canada, 58 Australia, 80 South Africa, 75 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 150MG, TABLET;ORAL - 200MG, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 10 Evonik, 5 Rochem International Inc, 23 SPI Pharma, 8 DKSH, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 8 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 38 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 1 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 4 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 10 Ideal Cures, 5 Ingredion Pharma Solutions, 27 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 14 Seppic, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 52 Direct Compression, 50 Disintegrants & Superdisintegrants, 44 Taste Masking, 40 Controlled & Modified Release, 39 Granulation, 34 Solubilizers, 29 Thickeners and Stabilizers, 26 Lubricants & Glidants, 24 Chewable & Orodispersible Aids, 24 Film Formers & Plasticizers, 20 Parenteral, 17 Topical, 17 Co-Processed Excipients, 8 Emulsifying Agents, 7 Rheology Modifiers, 7 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

44 News #PharmaBuzz

44 News #PharmaBuzz

GLOBAL SALES INFORMATION

43 US Medicaid Prescriptions, 140 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

11 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 12 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/10/2025	Polpharma	Poland	Wooshin Labotech Co., Ltd.	20210611-209-J-1025(1)	Lamotrigine	2021-11-01	Pharmaceutical Works Polpharma S.A.	Poland	19, Pelplinska street, 83-200 Starogard Gdanski, Poland
31/10/2025	Cohance Lifesciences	India	Wonpung Pharmaceutical Co., Ltd.	20220112-209-J-1158(A)	Lamotrigine	2022-12-12	Cohance Lifescience Limited	India	API Unit-I, RS 50/1, Mukteswarapuram Village, Jaggaiahpet Mandal, NTR District – 521 457, Andhra Pradesh, India

Lamictal

Lamictal

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

80 API Suppliers

33 USDMF

21 CEP/COS

5 JDMF

21 EU WC

10 KDMF

20 NDC API

43 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1205 FDF Dossiers

235 FDA Orange Book

725 Europe

32 Canada

58 Australia

80 South Africa

75 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG

TABLET;ORAL - 150MG

TABLET;ORAL - 200MG

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 25MG

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

10 Evonik

5 Rochem International Inc

23 SPI Pharma

8 DKSH

1 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

4 Kirsch Pharma

1 ACG Worldwide

8 Actylis

3 Aeon Procare

3 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

38 BASF

1 Bioplus Life Sciences

1 CD Formulation

1 Clariant

16 Corel Pharma Chem

7 DFE Pharma

4 Doshion Polyscience

1 Esteem Industries

1 Finar

13 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

10 Ideal Cures

5 Ingredion Pharma Solutions

27 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

20 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

5 Novo Excipients

5 Pharmatrans-Sanaq

9 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

TABLET;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons